FDA approves Syndax’s Revuforj for acute leukemia
The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute ...
Syndax confirms FDA approval of Revuforj for acute leukemia
Pharmaceuticals announced that the U.S. FDA has approved Revuforj as the first and only menin inhibitor for the treatment of ...
ophthalmologyadvisor7h
Photobiomodulation Treatment Receives FDA Authorization for Dry AMD Therapy
The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...
US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
GlobalData on MSN12h
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting the drug.
Family of mom who died after delayed abortion care says death was preventable
CBS News' Jericka Duncan spoke to Amber Thurman's family and the ProPublica reporter whose investigation found doctors waited ...
sloveniatimes17d
AIM Vaccine's heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
The STA web pages use cookies to ensure proper functioning of all page features. By using our website, you agree to the use of cookies on all STA web pages.
Health Check: Hold the front page for a rush of clinical trial updates
Quarterly reports from the biotech sector are falling from the skies like spring pollen and the wise companies are augmenting ...
Pharmaceutical Technology19d
FDA approves Iterum’s ORLYNVAH NDA for uUTI treatment
ORLYNVAH is indicated for the treatment of uUTIs in adult women. Credit: 9nong/Shutterstock. The US Food and Drug Administration (FDA) has approved Iterum Therapeutics‘ new drug application (NDA) for ...
MarketWatch21d
Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment
Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors — making it the first antitissue-factor pathway inhibitor to be allowed for ...
FiercePharma21d
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Sulopenem, which will now go by the commercial moniker Orlynvah, was approved by the FDA Friday to treat uncomplicated urinary tract infections (uUTIs) caused by E. coli, Klebsiella pneumoniae or ...